Short answer · Medically reviewed summary · Last updated: 2026-04-07
The primary treatment for Hyper IgE Syndrome (HIES), also known as Job syndrome, focuses on the chronic, prophylactic management of recurrent skin and pulmonary infections through long-term antibiotic and antifungal therapy. Standard Pharmacological Management Because Hyper IgE Syndrome is characterized by a deficient immune response to specific pathogens, patients are typically placed on lifelong prophylactic antibiotics (such as trimethoprim-sulfamethoxazole) to prevent Staphylococcus aureus infections. Antifungal medications (such as fluconazole) are also frequently utilized to manage persistent mucocutaneous candidiasis.
1 people with Hyper IgE Syndrome have shared their first-person experience on this question at DiseaseMaps.
The primary treatment for Hyper IgE Syndrome (HIES), also known as Job syndrome, focuses on the chronic, prophylactic management of recurrent skin and pulmonary infections through long-term antibiotic and antifungal therapy.
Because Hyper IgE Syndrome is characterized by a deficient immune response to specific pathogens, patients are typically placed on lifelong prophylactic antibiotics (such as trimethoprim-sulfamethoxazole) to prevent Staphylococcus aureus infections. Antifungal medications (such as fluconazole) are also frequently utilized to manage persistent mucocutaneous candidiasis. In cases where lung damage has occurred, such as the formation of pneumatoceles, aggressive treatment of respiratory infections is vital to prevent permanent bronchiectasis.
Skincare is a cornerstone of daily management for Hyper IgE Syndrome; clinicians often recommend daily diluted bleach baths and the consistent application of emollients to maintain the skin barrier and reduce the colonization of Staphylococcus. When patients develop large, symptomatic pneumatoceles or recurrent lung abscesses, surgical consultation for resection may be necessary. Physical therapy is also recommended for those experiencing chronic respiratory issues to aid in airway clearance.
Management of Hyper IgE Syndrome is highly personalized, as the clinical presentation—ranging from skeletal abnormalities to severe eczema—varies significantly between individuals. A robust care team should include an immunologist, a dermatologist, a pulmonologist, and an infectious disease specialist. Emerging research is currently focused on the role of biologics, such as monoclonal antibodies targeting the IL-6 or IgE pathways, to modulate the overactive inflammatory responses seen in some patients. Clinical trials are ongoing to determine the long-term safety and efficacy of these targeted therapies.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified health provider with any questions regarding a medical condition, as treatment plans for Hyper IgE Syndrome must be tailored to the individual’s specific genetic profile and clinical history.